Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
PubMed Central, Freitas, Silvia R., et al
As oral GLP1 drugs make their debut alongside established injectables, the conversation around obesity and type 2 diabetes is rapidly evolving
2021 Mar 13;10(6):1202
Tirzepatide works by targeting the dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor agonist, making it the first weight loss and diabetes care medication that targets 2 receptor agonists
US$ 28.31
US$ 27.54
US$ 24.45
US$ 25.51
US$ 24.80
